![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Short-Duration Therapy With Daclatasvir/Asunaprevir/Beclabuvir Fixed-Dose Combination Plus Sofosbuvir in Patients With Chronic Hepatitis C Genotype 1 (FOURward Study)
|
|
|
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Sulkowski M,1 Flamm S,2 Kayali Z,3 Lawitz E,4 Kwo P,5 McPhee F,6 Torbeyns A,7 Hughes EA,8 Swenson ES,6 Yin PD,6 Linaberry M8
1Johns Hopkins University, Baltimore, MD; 2Northwestern University, Chicago, IL; 3Inland Empire Liver Foundation, Rialto, CA; 4The Texas Liver Institute, University of Texas Health Center, San Antonio, TX; 5Indiana University, Indianapolis, IN; 6Bristol-Myers Squibb, Wallingford, CT; 7Bristol-Myers Squibb, Braine l'Alleud, Belgium; 8Bristol-Myers Squibb, Princeton, NJ
![AASLD1.gif](../images/120415/120415-1/AASLD1.gif)
![AASLD2.gif](../images/120415/120415-1/AASLD2.gif)
![AASLD3.gif](../images/120415/120415-1/AASLD3.gif)
![AASLD4.gif](../images/120415/120415-1/AASLD4.gif)
![AASLD5.gif](../images/120415/120415-1/AASLD5.gif)
![AASLD6.gif](../images/120415/120415-1/AASLD6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|